Neurotherapeutics

Title Publication Date Language Citations
Advanced Therapies for Movement Disorders in Neurotherapeutics2008/04/01English
A Model of the Extent and Impact of Inter-Rater Variability for the UHDRS Motor and Diagnostic Confidence Scales2008/04/01English
A Comparison of Two Brief Cognitive Screening Instruments in Huntington Disease (HD)2008/04/01English
HD Repeat Determines the Rate of Neuropathological Change2008/04/01English
Genetic Testing for the Huntingtin Gene CAG Repeat Comparing DNA from Buccal Swabs with DNA from Peripheral Blood2008/04/01English
Abnormal Structure of Cerebral White and Cortical Gray Matter in Preclinical Huntington’s Disease2008/04/01English
Controlling for Individual Differences in Neurocognitive Markers in Pre-Diagnosis HD in the PREDICT-HD Cohort2008/04/01English
A Randomized, Controlled Trial of Ethyl-EPA for the Treatment of Huntington Disease: 12-Month Results2008/04/01English
Predictive Value of CAG Repeat Length for HD Onset: Effects of Ethnicity, Demographic, and Clinical Variables2008/04/01English
Experimental Therapeutics for Huntington’s Disease: Challenges and Hurdles to Successful Clinical Development2008/04/01English
Huntington’s Disease: Causes and Place of Death in a Closely Followed Population2008/04/01English
The MLK Inhibitor, CEP-1347, Suppresses Mutant Huntingtin-Associated Neurotoxicity in Cell, Drosophila and Mouse Models of HD by Modulating MAPK Signaling and Upregulating Brain Derived Neurotrophic Factor2008/04/01English
COHORT: A Snapshot of Baseline Characteristics2008/04/01English
Contents2008/04/01English
Subtle Motor Abnormalities in Pre-Manifest HD Are Associated With Gene Status, Probability of Disease Onset, and Striatal Atrophy2008/04/01English
Long-Term Treatment with Olanzapine and Risperidone in Relation to Dystonia in Huntington’s Disease2008/04/01English
Break and poster viewing2008/04/01English
Plasma 8-OH2′dG As a Diagnostic and Pharmacodynamic Biomarker for HD2008/04/01English
Recruitment and Retention Strategies for PREDICT-HD Study at HSG Site 1442008/04/01English
SCA2 Mimicking Juvenile Onset HD: A Case Report2008/04/01English
Communicating Findings to Research Participants: Preliminary Results from the TREND-HD Study2008/04/01English
Abstract withdrawn2008/04/01English
How People With Huntington’s Disease Die: A Survey2008/04/01English
PREDICT-HD Family Participation in HSG Site 1442008/04/01English
Poster viewing2008/04/01English
Treatment of HD: A Survey of HD Clinicians2008/04/01English
Proposed Criteria for the Diagnosis of Dementia Associated With Huntington’s Disease (HD)2008/04/01English
Discovery and Development of Novel HDAC Inhibitors for Huntington’s Disease2008/04/01English
VEGF expression disparities in brainstem motor neurons of the SOD1G93A ALS model: Correlations with neuronal vulnerability2024/04/01English
Honokiol hexafluoro confers reversal of neuropathological markers of HIV infection in a murine SCID model2024/03/01English